Philip Morris sells asthma inhaler company amid ‘unwarranted opposition’ to its goals – NPR

by
  1. Philip Morris sells asthma inhaler company amid ‘unwarranted opposition’ to its goalsNPR
  2. Philip Morris sells Vectura for $198M after health care reform backlashReuters
  3. Philip Morris loses $220 million on sale of inhalation medicines unitThe Wall Street Journal
  4. Marlboro Manufacturer Sells Group of Asthma Inhalers at Discount After Adverse Health ReactionsFinancial Times
  5. Molex, a parent company of Phillips Medisize, announces agreement to acquire Vectura Group Limited, expanding its inhaled drug delivery capabilitiesBusiness news

Leave a Comment